IL1B and colitis: PA/CCMTS-P showed excellent anti-inflammatory effects both in vitro and in vivo, which obviously reduced the secretion of TNF-α, IL-6, IL-1β, and IL-18 after LPS stimulation in Raw264.7 cells, and the expression of IL-1β and IL-18 at the colitis site in vivo.